Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,730 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse].
Kurihara K, Sadato D, Najima Y, Hirama C, Haraguchi K, Kato K, Kondo K, Sadaga Y, Kato C, Sakai S, Kambara Y, Nabe Y, Teshima K, Asano K, Jinguji A, Shimabukuro M, Ouchi F, Inai K, Koi S, Shingai N, Toya T, Shimizu H, Kobayashi T, Oboki K, Harada H, Okuyama Y, Harada Y, Doki N. Kurihara K, et al. Among authors: kobayashi t. Rinsho Ketsueki. 2024;65(2):63-68. doi: 10.11406/rinketsu.65.63. Rinsho Ketsueki. 2024. PMID: 38447999 Japanese.
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
Yagi Y, Kanemasa Y, Sasaki Y, Hayashi Y, Mino M, Kato C, Sakai S, Ohigashi A, Kanbara Y, Morita Y, Tamura T, Atsuta Y, Konuma R, Nakamura S, Wada A, Okuya T, Kageyama A, Murakami D, Nakashima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Omuro Y, Shingai N, Shimizuguchi T, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Ohashi K, Doki N, Okuyama Y, Shimoyama T. Yagi Y, et al. Among authors: kobayashi t. Rinsho Ketsueki. 2022;63(10):1363-1372. doi: 10.11406/rinketsu.63.1363. Rinsho Ketsueki. 2022. PMID: 36351641 Japanese.
A third dose of COVID-19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant.
Toya T, Sadato D, Sanada T, Honda T, Atsuta Y, Sekiya N, Shimizu H, Najima Y, Kobayashi T, Harada Y, Kohara M, Doki N. Toya T, et al. Among authors: kobayashi t. EJHaem. 2022 Dec 22;4(1):309-11. doi: 10.1002/jha2.637. Online ahead of print. EJHaem. 2022. PMID: 36721642 Free PMC article. No abstract available.
Clinical impact and early prediction of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in allogeneic hematopoietic stem cell transplantation recipients.
Sakaguchi M, Atsuta Y, Sekiya N, Najima Y, Fukushima K, Shingai N, Toya T, Kobayashi T, Ohashi K, Doki N. Sakaguchi M, et al. Among authors: kobayashi t. J Glob Antimicrob Resist. 2023 Mar;32:187-194. doi: 10.1016/j.jgar.2023.02.001. Epub 2023 Feb 18. J Glob Antimicrob Resist. 2023. PMID: 36806701 Free article.
Identification of compounds that preferentially suppress the growth of T-cell acute lymphoblastic leukemia-derived cells.
Miyashita K, Yagi T, Kagaya N, Takechi A, Nakata C, Kanda R, Nuriya H, Tanegashima K, Hoyano S, Seki F, Yoshida C, Hachiro Y, Higashi T, Kitada N, Toya T, Kobayashi T, Najima Y, Goyama S, Maki SA, Kitamura T, Doki N, Shin-Ya K, Hara T. Miyashita K, et al. Among authors: kobayashi t. Cancer Sci. 2023 Oct;114(10):4032-4040. doi: 10.1111/cas.15918. Epub 2023 Jul 31. Cancer Sci. 2023. PMID: 37522388 Free PMC article.
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
Morita Y, Yagi Y, Kanemasa Y, Sasaki Y, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Tamura T, Nakamura S, Okuya T, Shimizuguchi T, Shingai N, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Doki N, Okuyama Y, Ohashi K, Shimoyama T. Morita Y, et al. Among authors: kobayashi t. Rinsho Ketsueki. 2023;64(7):586-595. doi: 10.11406/rinketsu.64.586. Rinsho Ketsueki. 2023. PMID: 37544717 Japanese.
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective study.
Yagi Y, Kanemasa Y, Sasaki Y, Sei M, Matsuo T, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Morita Y, Tamura T, Nakamura S, Okuya T, Shimizuguchi T, Shingai N, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Doki N, Okuyama Y, Shimoyama T. Yagi Y, et al. Among authors: kobayashi t. Cancer Med. 2023 Sep;12(17):17808-17821. doi: 10.1002/cam4.6412. Epub 2023 Aug 28. Cancer Med. 2023. PMID: 37635630 Free PMC article.
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation.
Shingai N, Ota A, Kato K, Kondo K, Sadaga Y, Kato C, Sakai S, Kambara Y, Nabe Y, Asano K, Teshima K, Kurihara K, Ouchi F, Fujiwara H, Shimabukuro M, Inai K, Jinguji A, Toya T, Shimizu H, Najima Y, Kobayashi T, Sugaya T, Ando M, Doki N. Shingai N, et al. Among authors: kobayashi t. Transplant Cell Ther. 2024 Jan;30(1):121.e1-121.e8. doi: 10.1016/j.jtct.2023.10.003. Epub 2023 Oct 7. Transplant Cell Ther. 2024. PMID: 37813188
Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation.
Kambara Y, Sadato D, Toya T, Honda A, Kato S, Hirama C, Haraguchi K, Shimizu H, Najima Y, Kobayashi T, Okuyama Y, Harada H, Takahashi S, Kurokawa M, Harada Y, Doki N. Kambara Y, et al. Among authors: kobayashi t. Leukemia. 2024 Mar;38(3):667-670. doi: 10.1038/s41375-024-02152-7. Epub 2024 Jan 18. Leukemia. 2024. PMID: 38238444 No abstract available.
[Kidney transplantation for end-stage renal disease after third allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Nishijima A, Shingai N, Ohta A, Suda K, Omoto K, Ishida S, Yoshioka K, Kurosawa S, Hino Y, Senoo Y, Igarashi A, Oshikawa G, Hamamura A, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Okuyama Y, Ohashi K, Doki N. Nishijima A, et al. Among authors: kobayashi t. Rinsho Ketsueki. 2024;65(1):7-12. doi: 10.11406/rinketsu.65.7. Rinsho Ketsueki. 2024. PMID: 38311391 Japanese.
14,730 results
You have reached the last available page of results. Please see the User Guide for more information.